why novartis� landmark cancer drug approval is great news for bluebird..
he said: "greater and immediate attention needs to be applied in these two areas.".
- .
- .
standard life and aviva clash over adviser charging.
he said: "greater and immediate attention needs to be applied in these two areas.".